1. Home
  2. LCTX vs LLAP Comparison

LCTX vs LLAP Comparison

Compare LCTX & LLAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCTX
  • LLAP
  • Stock Information
  • Founded
  • LCTX 1990
  • LLAP 2013
  • Country
  • LCTX United States
  • LLAP United States
  • Employees
  • LCTX N/A
  • LLAP N/A
  • Industry
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • LLAP Military/Government/Technical
  • Sector
  • LCTX Health Care
  • LLAP Industrials
  • Exchange
  • LCTX Nasdaq
  • LLAP Nasdaq
  • Market Cap
  • LCTX 165.6M
  • LLAP 165.7M
  • IPO Year
  • LCTX N/A
  • LLAP N/A
  • Fundamental
  • Price
  • LCTX $0.84
  • LLAP $0.24
  • Analyst Decision
  • LCTX Strong Buy
  • LLAP Buy
  • Analyst Count
  • LCTX 3
  • LLAP 3
  • Target Price
  • LCTX $5.67
  • LLAP $2.58
  • AVG Volume (30 Days)
  • LCTX 441.4K
  • LLAP 9.4M
  • Earning Date
  • LCTX 08-08-2024
  • LLAP 08-12-2024
  • Dividend Yield
  • LCTX N/A
  • LLAP N/A
  • EPS Growth
  • LCTX N/A
  • LLAP N/A
  • EPS
  • LCTX N/A
  • LLAP N/A
  • Revenue
  • LCTX $6,186,000.00
  • LLAP $133,107,000.00
  • Revenue This Year
  • LCTX N/A
  • LLAP $8.71
  • Revenue Next Year
  • LCTX $119.00
  • LLAP $34.59
  • P/E Ratio
  • LCTX N/A
  • LLAP N/A
  • Revenue Growth
  • LCTX N/A
  • LLAP 10.75
  • 52 Week Low
  • LCTX $0.77
  • LLAP $0.23
  • 52 Week High
  • LCTX $1.61
  • LLAP $1.62
  • Technical
  • Relative Strength Index (RSI)
  • LCTX 40.70
  • LLAP 24.59
  • Support Level
  • LCTX $0.84
  • LLAP $0.24
  • Resistance Level
  • LCTX $0.94
  • LLAP $0.30
  • Average True Range (ATR)
  • LCTX 0.05
  • LLAP 0.02
  • MACD
  • LCTX 0.00
  • LLAP 0.01
  • Stochastic Oscillator
  • LCTX 4.54
  • LLAP 2.95

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

About LLAP Terran Orbital Corporation

Terran Orbital Corp is a manufacturer of satellite products primarily serving the aerospace and defense industries. The company provide end-to-end satellite solutions by combining satellite design, production, launch planning, mission operations, and on-orbit support to meet the needs of our military, civil, and commercial customers. Geographically company operates in United States and Europe. Majority of the revenue is generated from United States.

Share on Social Networks: